臨床營養:全球市場展望至2031年
市場調查報告書
商品編碼
2069136

臨床營養:全球市場展望至2031年

Clinical Nutrition: Global Markets to 2031

出版日期: | 出版商: BCC Research | 英文 185 Pages | 訂單完成後即時交付

價格

全球臨床營養市場預計將從 2026 年的 795 億美元成長到 2031 年底的 1,047 億美元,在 2026 年至 2031 年的預測期內,複合年成長率將達到 5.6%。

預計北美臨床營養市場將從 2026 年的 373 億美元成長到 2030 年底的 493 億美元,在 2026 年至 2031 年的預測期內,複合年成長率將達到 5.7%。

歐洲臨床營養市場預計將從 2026 年的 236 億美元成長到 2030 年底的 307 億美元,在 2026 年至 2031 年的預測期內,複合年成長率將達到 5.4%。

調查範圍

本報告提供全球臨床營養市場的詳細資訊。報告利用2025年數​​據、2026年估計值、至2031年的複合年成長率(CAGR)預測(預測期:2026-2031年)以及區域臨床營養市場數據,分析了市場趨勢。報告重點關注臨床營養市場的當前和未來市場潛力,並對競爭格局進行了詳細分析。報告涵蓋監管趨勢、市場促進因素、阻礙因素和機遇,並提供了至2031年的市場預測以及主要參與者的市場佔有率數據。

本報告中的市場範圍按營養類型分類:嬰兒營養、經腸營養和腸外營養。此外,也依最終使用者分類:嬰兒、兒童、成人和老年人。

市場按主要區域分類,包括北美、歐洲、亞太、中東和非洲以及南美。報告對各區域內的主要國家進行了詳細分析,包括美國、加拿大、墨西哥、德國、英國、英國、義大利、西班牙、日本、中國、韓國、澳洲和印度。報告提供了市場估算和預測,包括2025年基準年的數據,以及2026年和2031年的預測數據。

本報告的目的如下:

  • 分析臨床營養的類型
  • 分析全球市場規模和細分。
  • 找出市場限制因素和市場刺激因素。
  • 提供至 2030 年的詳細市場預測。
  • 評估市場佔有率、競爭力和行業結構。
  • 確定對全球臨床營養市場的長期潛在影響。

本報告包含以下內容:

  • 數據表 78 及補充表 43
  • 臨床營養市場分析(包括當前市場規模和未來成長潛力)
  • 2025 年(基準年)市場規模估算及 2026 年至 2031 年預測。
  • 按類型和最終用戶分類的詳細市場細分
  • 分析影響市場成長的關鍵市場促進因素、阻礙因素和成長機會。
  • 深入了解產業趨勢、新興技術、專利分析以及臨床營養領域的最新進展。
  • 對主要地區的監管狀況進行評估
  • 區域市場分析,包括北美、歐洲、亞太地區和世界其他地區。
  • 競爭格局分析,包括市場佔有率、排名、產品定位分析以及主要公司的策略趨勢。
  • 介紹雀巢、達能、雅培、利潔時、大塚控股新興企業和費森尤斯卡比(包括產品系列、財務狀況和近期發展)。

目錄

第1章摘要整理

第2章 市場概覽

  • 概述
  • 宏觀經濟因素分析
  • 醫療費用
  • 地緣政治風險、貿易戰和供應鏈中斷
  • 人口老化
  • 波特五力分析
  • 產業競爭力

第3章 市場動態

  • 市場動態
  • 市場促進因素
  • 全球早產兒數量增加
  • 嬰幼兒和老年人的營養不良
  • 慢性病患者數量增加
  • 市場限制因素
  • 關於母乳哺育的爭論
  • 產品召回
  • 與還款相關的問題
  • 市場機遇
  • 癌症患者的營養不良
  • 新興市場

第4章 監管情勢

  • 概述
  • 美國
  • 歐洲
  • 亞太地區

第5章:新興技術與管道分析

  • 概述
  • 人工智慧(AI)
  • 營養基因體學
  • 臨床試驗分析
  • 依研究類型進行臨床試驗分析
  • 臨床試驗進展分析
  • 分階段臨床試驗分析
  • 專利分析
  • 主要申請人的專利
  • 按管轄權分類的專利

第6章 市場區隔分析

  • 細分市場
  • 全球臨床營養市場:依營養類別分類
  • 嬰幼兒營養食品
  • 經腸營養
  • 腸外營養
  • 全球臨床營養市場:依最終用戶分類
  • 嬰兒
  • 老年人
  • 孩子們
  • 成人
  • 按地區分類
  • 全球市場:按地區分類
  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 南美洲

第7章 競爭情勢

  • 競爭格局
  • 企業市場占有率分析

第8章附錄

  • 調查方法
  • 簡稱
  • 資訊來源
  • 公司簡介
  • ABBOTT
  • BAXTER
  • B. BRAUN SE
  • DANONE
  • DSM-FIRMENICH
  • FRESENIUS KABI AG
  • GLANBIA PLC
  • INTERNATIONAL FLAVORS & FRAGRANCES INC.
  • LONZA
  • MEIJI HOLDINGS CO. LTD.
  • NESTLE
  • OTSUKA HOLDINGS CO. LTD.
  • PERRIGO CO. PLC
  • PROLACTA
  • RECKITT
  • 市場新興企業
Product Code: PHM198C

The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.

The North American market for clinical nutrition is expected to grow from $37.3 billion in 2026 and is projected to reach $49.3 billion by the end of 2030, at a CAGR of 5.7% during the forecast period of 2026 to 2031.

The European market for clinical nutrition is expected to grow from $23.6 billion in 2026 and is projected to reach $30.7 billion by the end of 2030, at a CAGR of 5.4% during the forecast period of 2026 to 2031.

Report Scope

This report provides detailed information on the global clinical nutrition market. It analyzes market trends in clinical nutrition using data from 2025, estimates for 2026, projections of compound annual growth rates through 2031 (forecast period 2026-2031), and regional clinical nutrition markets. This report highlights clinical nutrition's current and future market potential and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2031 and the market share for key market companies.

The market scope in this report is segmented by nutrition type into infant nutrition, enteral nutrition, and parenteral nutrition. The market scope in this report is segmented by end users, which includes infants, children, adults, and geriatrics.

The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2025 because of the base year, with forecasts for 2026 and a forecast value for 2031.

The report aims to:

  • Analyze types of clinical nutrition.
  • Analyze global market size and segmentation.
  • Understand market constraints and drivers.
  • Provide detailed market forecasts for 2030.
  • Assess market shares, competitiveness, and industry structure.
  • Identify potential long-term impacts on the global clinical nutrition market.

Report Includes

  • 78 data tables and 43 additional tables
  • Analysis of the clinical nutrition market, including current market size and future growth potential
  • Market size estimates for 2025 (base year) and forecasts for the period 2026 through 2031
  • Detailed segmentation of the market by type and end user
  • Analysis of key market drivers, restraints, and opportunities influencing market growth
  • Insights into industry trends, emerging technologies, patent analysis and developments in clinical nutrition
  • Evaluation of the regulatory landscape across major regions
  • Analysis of regional markets, including North America, Europe, Asia-Pacific and Rest of the World
  • Competitive landscape analysis, including market share, ranking, product mapping analysis and strategic developments of key players
  • Profiles of leading and emerging companies, including their product portfolios, financials, and recent developments, including Nestle, Danone, Abbott, Reckitt, Otsuka Holdings Co. Ltd., and Fresenius Kabi AG

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary
  • Market Dynamics and Growth Factors
  • Emerging Technologies
  • Segmental Analysis
  • Regional Analysis
  • Conclusion

Chapter 2 Market Overview

  • Overview
  • Macroeconomic Factor Analysis
  • Healthcare Expenditure
  • Geopolitical Risks, Trade Wars, and Supply Chain Disruptions
  • Aging Population
  • Porter's Five Forces Analysis
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Potential for New Entrants
  • Threat of Substitutes
  • Competitiveness in the Industry

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Increasing Incidence of Preterm Births Worldwide
  • Malnutrition in Infants and the Geriatric Population
  • Rising Cases of Chronic Diseases
  • Market Restraints
  • Breast Milk Debate
  • Product Recalls
  • Reimbursement Issues
  • Market Opportunities
  • Malnutrition in Oncology Patients
  • Emerging Markets

Chapter 4 Regulatory Landscape

  • Overview
  • U.S.
  • Europe
  • Asia-Pacific

Chapter 5 Emerging Technologies and Pipeline Analysis

  • Overview
  • Artificial Intelligence (AI)
  • Nutrigenomics
  • Clinical Trial Analysis
  • Clinical Trials Analysis by Type of Study
  • Clinical Trials Analysis by Status
  • Clinical Trials Analysis by Phase
  • Patent Analysis
  • Patents by Top Applicant
  • Patents by Jurisdiction
  • Key Takeaways

Chapter 6 Market Segmentation Analysis

  • Segmentation Breakdown
  • Global Market for Clinical Nutrition, by Nutrition
  • Key Takeaways
  • Infant Nutrition
  • Enteral Nutrition
  • Parenteral Nutrition
  • Global Clinical Nutrition Market, by End User
  • Key Takeaways
  • Infants
  • Geriatrics
  • Children
  • Adults
  • Geographic Breakdown
  • Global Market for Clinical Nutrition, by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America

Chapter 7 Competitive Intelligence

  • Key Takeaways
  • Competitive Landscape
  • Company Share Analysis

Chapter 8 Appendix

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • ABBOTT
  • BAXTER
  • B. BRAUN SE
  • DANONE
  • DSM-FIRMENICH
  • FRESENIUS KABI AG
  • GLANBIA PLC
  • INTERNATIONAL FLAVORS & FRAGRANCES INC.
  • LONZA
  • MEIJI HOLDINGS CO. LTD.
  • NESTLE
  • OTSUKA HOLDINGS CO. LTD.
  • PERRIGO CO. PLC
  • PROLACTA
  • RECKITT
  • Emerging Companies in the Global Clinical Nutrition Market

List of Tables

  • Summary Table : Global Market for Clinical Nutrition, by Region, Through 2031
  • Table 1 : Current Health Expenditure
  • Table 2 : Rheumatoid Arthritis - Level 3 Cause, 2021
  • Table 3 : Global HIV Epidemic, by Age Group, 2023
  • Table 4 : Clinical Trials in Clinical Nutrition, by Type of Study, as of April 2026
  • Table 5 : Clinical Trials in Clinical Nutrition, by Status, as of April 2026
  • Table 6 : Clinical Trials in Clinical Nutrition, by Phase, as of April 2026
  • Table 7 : Patents Granted for Clinical Nutrition, by Top Applicant
  • Table 8 : Patents Granted for Clinical Nutrition, by Jurisdiction
  • Table 9 : Global Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 10 : Global Market for Infant Nutrition in Clinical Nutrition, by Region, Through 2031
  • Table 11 : Global Market for Infant Nutrition in Clinical Nutrition, by Type, Through 2031
  • Table 12 : Global Market for Enteral Nutrition in Clinical Nutrition, by Region, Through 2031
  • Table 13 : Global Market for Enteral Nutrition in Clinical Nutrition, by Type, Through 2031
  • Table 14 : Global Market for Parenteral Nutrition in Clinical Nutrition, by Region, Through 2031
  • Table 15 : Global Market for Parenteral Nutrition in Clinical Nutrition, by Type, Through 2031
  • Table 16 : Global Market for Clinical Nutrition, by End User, Through 2031
  • Table 17 : Global Market for Clinical Nutrition for Infants, by Region, Through 2031
  • Table 18 : Global Market for Clinical Nutrition for Geriatrics, by Region, Through 2031
  • Table 19 : Global Market for Clinical Nutrition for Children, by Region, Through 2031
  • Table 20 : Global Market for Clinical Nutrition for Adults, by Region, Through 2031
  • Table 21 : Global Market for Clinical Nutrition, by Region, Through 2031
  • Table 22 : North American Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 23 : North American Market for Clinical Nutrition, by End User, Through 2031
  • Table 24 : North American Market for Clinical Nutrition, by Country, Through 2031
  • Table 25 : U.S. Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 26 : U.S. Market for Clinical Nutrition, by End User, Through 2031
  • Table 27 : Canadian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 28 : Canadian Market for Clinical Nutrition, by End User, Through 2031
  • Table 29 : Mexican Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 30 : Mexican Market for Clinical Nutrition, by End User, Through 2031
  • Table 31 : European Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 32 : European Market for Clinical Nutrition, by End User, Through 2031
  • Table 33 : European Market for Clinical Nutrition, by Country, Through 2031
  • Table 34 : German Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 35 : German Market for Clinical Nutrition, by End User, Through 2031
  • Table 36 : U.K. Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 37 : U.K. Market for Clinical Nutrition, by End User, Through 2031
  • Table 38 : French Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 39 : French Market for Clinical Nutrition, by End User, Through 2031
  • Table 40 : Italian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 41 : Italian Market for Clinical Nutrition, by End User, Through 2031
  • Table 42 : Spanish Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 43 : Spanish Market for Clinical Nutrition, by End User, Through 2031
  • Table 44 : Rest of Europe Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 45 : Rest of Europe Market for Clinical Nutrition, by End User, Through 2031
  • Table 46 : Asia-Pacific Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 47 : Asia-Pacific Market for Clinical Nutrition, by End User, Through 2031
  • Table 48 : Asia-Pacific Market for Clinical Nutrition, by Country, Through 2031
  • Table 49 : Chinese Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 50 : Chinese Market for Clinical Nutrition, by End User, Through 2031
  • Table 51 : Japanese Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 52 : Japanese Market for Clinical Nutrition, by End User, Through 2031
  • Table 53 : Indian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 54 : Indian Market for Clinical Nutrition, by End User, Through 2031
  • Table 55 : South Korean Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 56 : South Korean Market for Clinical Nutrition, by End User, Through 2031
  • Table 57 : Australian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 58 : Australian Market for Clinical Nutrition, by End User, Through 2031
  • Table 59 : Rest of Asia-Pacific Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 60 : Rest of Asia-Pacific Market for Clinical Nutrition, by End User, Through 2031
  • Table 61 : Middle East and African Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 62 : Middle East and African Market for Clinical Nutrition, by End User, Through 2031
  • Table 63 : Middle East and African Market for Clinical Nutrition, by Country, Through 2031
  • Table 64 : Middle Eastern Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 65 : Middle Eastern Market for Clinical Nutrition, by End User, Through 2031
  • Table 66 : African Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 67 : African Market for Clinical Nutrition, by End User, Through 2031
  • Table 68 : South American Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 69 : South American Market for Clinical Nutrition, by End User, Through 2031
  • Table 70 : South American Market for Clinical Nutrition, by Country, Through 2031
  • Table 71 : Brazilian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 72 : Brazilian Market for Clinical Nutrition, by End User, Through 2031
  • Table 73 : Argentine Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 74 : Argentine Market for Clinical Nutrition, by End User, Through 2031
  • Table 75 : Rest of South America Market for Clinical Nutrition, by Type of Nutrition, Through 2031
  • Table 76 : Rest of South America Market for Clinical Nutrition, by End User, Through 2031
  • Table 77 : Abbreviations Used in this Report
  • Table 78 : Report Sources
  • Table 79 : Abbott: Company Snapshot
  • Table 80 : Abbott: Financial Performance, FY 2024 and 2025
  • Table 81 : Abbott: Product Portfolio
  • Table 82 : Abbott: News/Key Developments, 2024-2026
  • Table 83 : Baxter: Company Snapshot
  • Table 84 : Baxter: Financial Performance, FY 2024 and 2025
  • Table 85 : Baxter: Product Portfolio
  • Table 86 : Baxter: News/Key Developments, 2024
  • Table 87 : B. Braun SE: Company Snapshot
  • Table 88 : B. Braun SE: Financial Performance, FY 2024 and 2025
  • Table 89 : B. Braun SE: Product Portfolio
  • Table 90 : Danone: Company Snapshot
  • Table 91 : Danone: Financial Performance, FY 2024 and 2025
  • Table 92 : Danone: Product Portfolio
  • Table 93 : Danone: News/Key Developments, 2024-2026
  • Table 94 : dsm-firmenich: Company Snapshot
  • Table 95 : dsm-firmenich: Financial Performance, FY 2024 and 2025
  • Table 96 : dsm-firmenich: Product Portfolio
  • Table 97 : dsm-firmenich: News/Key Developments, 2024-2026
  • Table 98 : Fresenius Kabi AG: Company Snapshot
  • Table 99 : Fresenius Kabi AG: Financial Performance, FY 2024 and 2025
  • Table 100 : Fresenius Kabi AG: Product Portfolio
  • Table 101 : Fresenius Kabi AG: News/Key Developments, 2024-2025
  • Table 102 : Glanbia PLC: Company Snapshot
  • Table 103 : Glanbia PLC: Financial Performance, FY 2024 and 2025
  • Table 104 : Glanbia PLC.: Product Portfolio
  • Table 105 : International Flavors & Fragrances Inc.: Company Snapshot
  • Table 106 : International Flavors & Fragrances Inc.: Financial Performance, FY 2024 and 2025
  • Table 107 : International Flavors & Fragrances Inc.: Product Portfolio
  • Table 108 : Lonza: Company Snapshot
  • Table 109 : Lonza: Financial Performance, FY 2024 and 2025
  • Table 110 : Lonza: Product Portfolio
  • Table 111 : Meiji Holdings Co. Ltd.: Company Snapshot
  • Table 112 : Meiji Holdings Co. Ltd.: Financial Performance, FY 2024 and 2025
  • Table 113 : Meiji Holdings Co. Ltd.: Product Portfolio
  • Table 114 : Meiji Holdings Co. Ltd.: News/Key Developments, 2025-2026
  • Table 115 : Nestle: Company Snapshot
  • Table 116 : Nestle: Financial Performance, FY 2024 and 2025
  • Table 117 : Nestle: Product Portfolio
  • Table 118 : Nestle: News/Key Developments, 2026
  • Table 119 : Otsuka Holdings Co. Ltd.: Company Snapshot
  • Table 120 : Otsuka Holdings Co. Ltd.: Financial Performance, FY 2024 and 2025
  • Table 121 : Otsuka Holdings Co. Ltd.: Product Portfolio
  • Table 122 : Otsuka Holdings Co. Ltd.: News/Key Developments, 2024-2025
  • Table 123 : Perrigo Co. plc: Company Snapshot
  • Table 124 : Perrigo Co. plc: Financial Performance, FY 2024 and 2025
  • Table 125 : Perrigo Co. plc: Product Portfolio
  • Table 126 : Perrigo Co. plc: News/Key Developments, 2024
  • Table 127 : Prolacta: Company Snapshot
  • Table 128 : Prolacta: Product Portfolio
  • Table 129 : Prolacta: News/Key Developments, 2024-2026
  • Table 130 : Reckitt: Company Snapshot
  • Table 131 : Reckitt: Financial Performance, FY 2024 and 2025
  • Table 132 : Reckitt: Product Portfolio
  • Table 133 : Emerging Companies in the Global Clinical Nutrition Market

List of Figures

  • Summary Figure : Global Market Shares of Clinical Nutrition, by Region, 2025
  • Figure 1 : Porter's Five Forces Analysis of the Global Clinical Nutrition Market
  • Figure 2 : Market Dynamics of Clinical Nutrition
  • Figure 3 : Distribution Share of the Most Frequent Cancer Types in Women*, 2022
  • Figure 4 : Distribution Share of the Most Frequent Cancer Types in Men*, 2022
  • Figure 5 : Estimated New Cancer Cases and Deaths in the U.S. in 2024
  • Figure 6 : Global Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 7 : Global Market Shares of Infant Nutrition in Clinical Nutrition, by Region, 2025
  • Figure 8 : Global Market Shares of Infant Nutrition in Clinical Nutrition, by Type, 2025
  • Figure 9 : Global Market Shares of Enteral Nutrition in Clinical Nutrition, by Region, 2025
  • Figure 10 : Global Market Shares of Enteral Nutrition in Clinical Nutrition, by Type, 2025
  • Figure 11 : Global Market Shares of Parenteral Nutrition in Clinical Nutrition, by Region, 2025
  • Figure 12 : Global Market Shares of Parenteral Nutrition in Clinical Nutrition, by Type, 2025
  • Figure 13 : Global Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 14 : Global Market Shares of Clinical Nutrition for Infants, by Region, 2025
  • Figure 15 : Global Market Shares of Clinical Nutrition for Geriatrics, by Region, 2025
  • Figure 16 : Global Market Shares of Clinical Nutrition for Children, by Region, 2025
  • Figure 17 : Global Market Shares of Clinical Nutrition for Adults, by Region, 2025
  • Figure 18 : Global Market Shares of Clinical Nutrition, by Region, 2025
  • Figure 19 : North American Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 20 : North American Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 21 : North American Market Shares of Clinical Nutrition, by Country, 2025
  • Figure 22 : U.S. Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 23 : U.S. Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 24 : Canadian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 25 : Canadian Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 26 : Mexican Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 27 : Mexican Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 28 : European Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 29 : European Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 30 : European Market Shares of Clinical Nutrition, by Country, 2025
  • Figure 31 : German Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 32 : German Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 33 : U.K. Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 34 : U.K. Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 35 : French Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 36 : French Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 37 : Italian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 38 : Italian Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 39 : Spanish Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 40 : Spanish Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 41 : Rest of Europe Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 42 : Rest of Europe Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 43 : Asia-Pacific Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 44 : Asia-Pacific Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 45 : Asia-Pacific Market Shares of Clinical Nutrition, by Country, 2025
  • Figure 46 : Chinese Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 47 : Chinese Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 48 : Japanese Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 49 : Japanese Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 50 : Indian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 51 : Indian Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 52 : South Korean Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 53 : South Korean Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 54 : Australian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 55 : Australian Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 56 : Rest of Asia-Pacific Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 57 : Rest of Asia-Pacific Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 58 : Middle East and African Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 59 : Middle East and African Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 60 : Middle East and African Market Shares of Clinical Nutrition, by Country, 2025
  • Figure 61 : Middle East Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 62 : Middle East Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 63 : African Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 64 : African Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 65 : South American Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 66 : South American Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 67 : South American Market Shares of Clinical Nutrition, by Country, 2025
  • Figure 68 : Brazilian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 69 : Brazilian Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 70 : Argentine Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 71 : Argentine Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 72 : Rest of South America Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
  • Figure 73 : Rest of South America Market Shares of Clinical Nutrition, by End User, 2025
  • Figure 74 : Global Market Shares of Clinical Nutrition, by Company, 2025
  • Figure 75 : Abbott: Revenue Shares, by Business Unit, FY 2025
  • Figure 76 : Abbott: Revenue Shares, by Region/Country, FY 2025
  • Figure 77 : Baxter: Revenue Shares, by Business Unit, FY 2025
  • Figure 78 : Baxter: Revenue Shares, by Country/Region, FY 2025
  • Figure 79 : B. Braun SE: Revenue Shares, by Business Unit, FY 2025
  • Figure 80 : B. Braun SE: Revenue Shares, by Country/Region, FY 2025
  • Figure 81 : Danone: Revenue Shares, by Business Unit, FY 2025
  • Figure 82 : Danone: Revenue Shares, by Country/Region, FY 2025
  • Figure 83 : dsm-firmenich: Revenue Shares, by Business Unit, FY 2025
  • Figure 84 : Glanbia PLC: Revenue Shares, by Business Unit, FY 2025
  • Figure 85 : Glanbia PLC: Revenue Shares, by Country/Region, FY 2025
  • Figure 86 : International Flavors & Fragrances Inc.: Revenue Shares, by Business Unit, FY 2025
  • Figure 87 : International Flavors & Fragrances Inc.: Revenue Shares, by Country/Region, FY 2025
  • Figure 88 : Lonza: Revenue Shares, by Business Unit, FY 2025
  • Figure 89 : Lonza: Revenue Shares, by Country/Region, FY 2025
  • Figure 90 : Meiji Holdings Co. Ltd.: Revenue Shares, by Business Unit, FY 2025
  • Figure 91 : Nestle: Revenue Shares, by Business Unit, FY 2025
  • Figure 92 : Nestle: Revenue Shares, by Country/Region, FY 2025
  • Figure 93 : Otsuka Holdings Co. Ltd.: Revenue Shares, by Business Unit, FY 2025
  • Figure 94 : Perrigo Co. plc: Revenue Shares, by Business Unit, FY 2025
  • Figure 95 : Reckitt: Revenue Shares, by Business Unit, FY 2025
  • Figure 96 : Reckitt: Revenue Shares, by Country/Region, FY 2025